Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.12 NOK | +1.64% | -6.00% | -56.40% |
05-29 | BerGenBio ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-29 | Transcript : BerGenBio ASA, Q1 2024 Earnings Call, May 29, 2024 |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
43.66M | - | - | ||||
125B | ||||||
108B | ||||||
23.64B | - | |||||
22.39B | - | |||||
17.78B |
- Stock Market
- Equities
- BGBIO Stock
- Charts BerGenBio ASA
- Sector Chart